# Hybrid Coronary Revascularization Trial

> **NCT03089398** · NA · COMPLETED · sponsor: **Emilia Bagiella** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Hybrid Coronary Revascularization (isolated LIMA-LAD)
- **DEVICE:** Hybrid Coronary Revascularization (PCI)
- **DEVICE:** Percutaneous Coronary Intervention

## Key facts

- **NCT ID:** NCT03089398
- **Lead sponsor:** Emilia Bagiella
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-09
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03089398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03089398, "Hybrid Coronary Revascularization Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03089398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*